The present invention relates to an amine compound having a fused ring that can be employed in various organic layers in an organic light-emitting device, and a high-efficiency organic light-emitting device comprising same and having significantly improved luminous efficiency. The amine compound having a fused ring, according to the present invention, makes it possible to implement a high-efficiency organic light-emitting device by being employed as an organic layer in the device, particularly as a hole transport or electron blocking material, and thus can be industrially utilized in a flat panel display device, a flexible display device, a monochromatic or white flat panel lighting device, a monochromatic or white flexible lighting device, a vehicle display device, a virtual or augmented reality display device, and the like.

A lithium battery includes a cathode including a cathode active material, an anode including an anode active material, and an organic electrolytic solution between the cathode and the anode. The organic electrolytic solution includes a first lithium salt, a second lithium salt different from the first lithium salt, an organic solvent, and a bicyclic sulfate-based compound represented by Formula 1 below: ##STR00001##
wherein, in Formula 1, each of A1, A2, A3, and A4 is independently a covalent bond, a substituted or unsubstituted C1-C5 alkylene group, a carbonyl group, or a sulfinyl group, wherein both A1 and A2 are not a covalent bond and both A3 and A4 are not a covalent bond.

A lithium battery includes a cathode including a cathode active material, an anode including an anode active material, and an organic electrolytic solution between the cathode and the anode. The organic electrolytic solution includes a first lithium salt, a second lithium salt different from the first lithium salt, an organic solvent, and a bicyclic sulfate-based compound represented by Formula 1 below: ##STR00001##
wherein, in Formula 1, each of A1, A2, A3, and A4 is independently a covalent bond, a substituted or unsubstituted C1-C5 alkylene group, a carbonyl group, or a sulfinyl group, wherein both A1 and A2 are not a covalent bond and both A3 and A4 are not a covalent bond.

A lithium battery includes a cathode including a cathode active material, an anode including an anode active material, and an organic electrolytic solution between the cathode and the anode. The anode active material includes a metal-based anode active material. The organic electrolytic solution includes a first lithium salt; an organic solvent; and a bicyclic sulfate-based compound represented by Formula 1 below: ##STR00001##
wherein, in Formula 1, each of A1, A2, A3, and A4 is independently a covalent bond, a substituted or unsubstituted C1-C5 alkylene group, a carbonyl group, or a sulfinyl group, wherein both A1 and A2 are not a covalent bond and both A3 and A4 are not a covalent bond.

A lithium battery includes a cathode including a cathode active material, an anode including an anode active material, and an organic electrolytic solution between the cathode and the anode. The anode active material includes a metal-based anode active material. The organic electrolytic solution includes a first lithium salt; an organic solvent; and a bicyclic sulfate-based compound represented by Formula 1 below: ##STR00001##
wherein, in Formula 1, each of A1, A2, A3, and A4 is independently a covalent bond, a substituted or unsubstituted C1-C5 alkylene group, a carbonyl group, or a sulfinyl group, wherein both A1 and A2 are not a covalent bond and both A3 and A4 are not a covalent bond.

The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

##STR00001##

An organic electrolytic solution, including a first lithium salt, an organic solvent, and a bicyclic sulfate-based compound represented by Formula 1 below:

##STR00001##

wherein, in Formula 1, each of A1, A2, A3, and A4 is independently a covalent bond, a substituted or unsubstituted C1-C5 alkylene group, a carbonyl group, or a sulfinyl group, wherein both A1 and A2 are not a covalent bond and both A3 and A4 are not a covalent bond.

A lithium battery includes a cathode including a cathode active material; an anode including an anode active material; and an organic electrolytic solution between the cathode and the anode, wherein the anode active material includes natural graphite and artificial graphite, an amount of the artificial graphite being about 50 wt % or more based on a total weight of the anode active material, and the organic electrolytic solution includes: a first lithium salt; an organic solvent; and a bicyclic sulfate-based compound represented by Formula 1 below: ##STR00001## wherein, in Formula 1, each of A.sub.1, A.sub.2, A.sub.3, and A.sub.4 is independently a covalent bond, a substituted or unsubstituted C.sub.1-C.sub.5 alkylene group, a carbonyl group, or a sulfinyl group, in which both A.sub.1 and A.sub.2 are not a covalent bond and both A.sub.3 and A.sub.4 are not a covalent bond.

A lithium battery includes a cathode including a cathode active material; an anode including an anode active material; and an organic electrolytic solution between the cathode and the anode, wherein the anode active material includes natural graphite and artificial graphite, an amount of the artificial graphite being about 50 wt % or more based on a total weight of the anode active material, and the organic electrolytic solution includes: a first lithium salt; an organic solvent; and a bicyclic sulfate-based compound represented by Formula 1 below: ##STR00001## wherein, in Formula 1, each of A.sub.1, A.sub.2, A.sub.3, and A.sub.4 is independently a covalent bond, a substituted or unsubstituted C.sub.1-C.sub.5 alkylene group, a carbonyl group, or a sulfinyl group, in which both A.sub.1 and A.sub.2 are not a covalent bond and both A.sub.3 and A.sub.4 are not a covalent bond.

The invention provides a labeling composition for an intraocular tissue of a living individual, which specifically labels the intraocular tissue without need of an invasive operation such as exposure of an ocular tissue or injection of a staining agent into the ocular tissue or a nerve tissue linking to the ocular tissue, a method of noninvasively labeling an intraocular tissue of a living individual, and a screening method using the labeling composition for the intraocular tissues. The composition contains a compound capable of labeling at least a photoreceptor cell layer of a retina, wherein the compound is a staining compound having a particular structure as a partial structure thereof.